key: cord-0807422-3zeq29za
authors: Jain, Shubhika; Rocha, Ian Christopher N; Maheshwari, Chanchal; dos Santos Costa, Ana Carla; Tsagkaris, Christos; Aborode, Abdullahi Tunde; Essar, Mohammad Yasir; Ahmad, Shoaib
title: Chikungunya and COVID‐19 in Brazil: The danger of an overlapping crises
date: 2021-04-01
journal: J Med Virol
DOI: 10.1002/jmv.26952
sha: 323f863ac2849568bfbd20952eb1ad855bcd074c
doc_id: 807422
cord_uid: 3zeq29za

It is already widely known that the COVID-19 pandemic has added a heavy burden to the health care system in different parts of the world. In Brazil, the situation was no different. The uncontrolled increase in the contagion curve of the disease has tested the limits of the country's health system. This situation is aggravated by the coexistence of an outbreak of Chikungunya, which affects mainly the most vulnerable groups in the country. The overlap of these two crises can be a dangerous combination if urgent measures are not taken. This article is protected by copyright. All rights reserved.

may be weakened to have severe pulmonary discomfort, requiring hospitalization in intensive care units. 11 Thus, the right diagnosis is a necessity to reduce the terminal course of both the disease and also to decrease the burden on the health system.

Despite what the figures show, the Chikungunya epidemic is far from declining in Brazil. Due to the the inaccessibility to basic sanitation services, such as piped water supply, especially in poor communities, 11 many individuals and communities are storing water in their homes, enabling mosquitoes to reproduce and proliferate. 12 This situation, which was already serious in the pre-pandemic period, has been aggravated since the beginning of 2020, when the focus of epidemiological surveillance services was redirected to the control of COVID-19.

To address this problem, the federal government, in cooperation with the Brazilian Ministry of Health, can mobilize community health workers to initiate health literacy campaigns emphasizing the prevention strategies and clinical features of CHIKV and COVID-19 transmission. It is vital that these campaigns reach as many individuals possible, and particularly, the affected and at-risk populations. 13, 14 The World Health Organization has also been encouraging and supporting the federal government to develop the capacity to detect, differentiate, and confirm both CHIKV and COVID-19 cases, manage patients individually, and execute public health strategies to prevent transmissions. 14 Double laboratory work-ups could be implemented to avoid misdiagnosis of both arboviral and COVID-19 infections.

Overall, Chikungunya represents an emerging exotic disease that spreads quickly, that must be dealt with a concrete response including but not limited to research, diagnostic tests, therapeutic agents, interventions, and vaccines. The overlapping crisis of COVID-19

represents not only a challenge, but also an opportunity to build a robust response strategy towards exotic diseases in Brazil. 

WHO Coronavirus disease (COVID-19) dashboard. Who.int., Accessed March 14 World Health Organization

Monitoramento dos casos de arboviroses urbanas transmitidas pelo Aedes (dengue

Chikungunya, and other emerging vector-borne viral diseases

Arboviroses e Determinantes Ambientais: impactos na saúde urbana

Covert cases of severe acute respiratory syndrome coronavirus 2: an obscure but present danger in regions endemic for Dengue and Chikungunya viruses

Emergence and potential for spread of Chikungunya virus in Brazil

Clinical characteristics of Coronavirus disease 2019 in China

The arboviral burden of disease caused by co-circulation and co-infection of dengue, chikungunya and Zika in the Americas

A skeleton in the closet: the implications of COVID-19 on XDR strain of typhoid in Pakistan

Concerns about COVID-19 and arboviral (chikungunya, dengue, zika) concurrent outbreaks

Mosquitoes and Covid-19 are a ticking time bomb for Latin America. Lse.ac.uk